金花股份致力于推動(dòng)骨骼肌肉領(lǐng)域?qū)W科發(fā)展,持續(xù)開展上市后臨床研究,潛心夯實(shí)循證證據(jù),助力提升臨床診療。近日,一項(xiàng)《The Efficacy and Safety of Bionic Tiger Bone Powder for the Treatment of Knee Osteoarthritis in Early Stage: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial》研究成果發(fā)布于《ORIGINAL RESEARCH》雜志,研究權(quán)威性高、影響因子大。為金天格治療KOA又添力證。